\section*{Introduction}

The Australian Ovarian Cancer Study (AOCS)\cite{Patch_2015} performed whole genome sequencing on 93 high grade serous Ovarian cancer tumors, including 12 donors with both primary and recurrence samples. Here we analyze the neoantigen burden burden of these paired tumors 